Tenaya Therapeutics, South San Francisco (United States of America)
Membership:
ESC Professional Member
Follow
Contributor content
Presentation
Low seroprevalence of neutralizing antibodies to adeno-associated virus serotype 9 in preparation for MyPEAK-1 study of TN-201 for individuals with MYBPC3-associated hypertrophic cardiomyopathy
